AI assistant
Beam Therapeutics Inc. — Director's Dealing 2021
Apr 23, 2021
31533_dirs_2021-04-23_df571f8f-eab9-4d9d-af03-365ae1bdb5e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-04-21
Reporting Person: Evans John M. (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-21 | Common Stock | S | 1463 | $67.90 | Disposed | 1038966 | Direct |
| 2021-04-21 | Common Stock | S | 5079 | $69.02 | Disposed | 1033887 | Direct |
| 2021-04-21 | Common Stock | S | 5595 | $70.23 | Disposed | 1028292 | Direct |
| 2021-04-21 | Common Stock | S | 9869 | $71.38 | Disposed | 1018423 | Direct |
| 2021-04-21 | Common Stock | S | 2994 | $71.79 | Disposed | 1015429 | Direct |
| 2021-04-23 | Common Stock | M | 6000 | $1.03 | Acquired | 1021429 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-23 | Stock Option (Right to Buy) | $1.03 | M | 6000 | Disposed | 2028-07-13 | Common Stock (6000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 223000 | Indirect |
Footnotes
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: These shares were sold in multiple transactions ranging from $67.67 to $68.00 inclusive.
F3: These shares were sold in multiple transactions ranging from $68.67 to $69.55 inclusive.
F4: These shares were sold in multiple transactions ranging from $69.68 to $70.68 inclusive.
F5: These shares were sold in multiple transactions ranging from $70.68 to $71.66 inclusive.
F6: These shares were sold in multiple transactions ranging from $71.68 to $71.92 inclusive.
F7: The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested.